Xtant Medical Holdings, Inc.
XTNT- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001453593
No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.
Holders of 5% or more of XTNT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Xtant Medical Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13D/A | 49.10%68.4M shares | 0.00 ppfrom 49.10% | Nov 14, 20243 filings | Aug 5, 2025 | SEC |
| Lytton Laurence W | 13G/A | 6.50%9.18M shares | +1.00 ppfrom 5.50% | Apr 16, 20253 filings | Nov 16, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
19 Schedule 13D and 13G filings on Xtant Medical Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 20265:29 PM ET | Lytton Laurence Wand 1 other | 13G/A | 6.50%9.18M shares | +1.00 ppfrom 5.50% | Sep 30, 2026 | SEC |
| Feb 17, 202612:57 PM ET | Lytton Laurence Wand 1 other | 13G/A | 5.50%7.70M shares | −1.30 ppfrom 6.80% | Dec 31, 2025 | SEC |
| Aug 5, 20254:30 PM ET | Nantahala Capital Management, LLCand 3 others | 13D/A | 49.10%68.4M shares | 0.00 ppfrom 49.10% | Aug 1, 2025 | SEC |
| Apr 17, 20254:31 PM ET | Nantahala Capital Management, LLCand 3 others | 13D | 49.10%68.4M shares | +40.89 ppfrom 8.21% | Apr 10, 2025 | SEC |
| Apr 16, 20252:11 PM ET | Lytton Laurence W | 13G | 6.80%9.46M shares | New | Apr 15, 2025 | SEC |
| Apr 14, 20257:09 PM ET | OrbiMed Advisors LLCand 1 other | 13D/A | 0.00%0 shares | –Below 5% | Apr 10, 2025 | SEC |
| Nov 14, 20244:53 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 8.21%11.4M shares | New | Sep 30, 2024 | SEC |
| Sep 10, 2024 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Altium Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Aug 3, 2023 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| May 5, 2023 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Altium Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Sep 6, 2022 | Vizirgianakis Stavros G. | 13DOld format | – | New | – | SEC |
| Aug 30, 2022 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Altium Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Apr 9, 2021 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Mar 8, 2021 | Altium Capital Management LP | 13GOld format | – | New | – | SEC |
| Feb 26, 2021 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Park West Asset Management LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Xtant Medical Holdings, Inc. shares.
No Form 144 notices for Xtant Medical Holdings, Inc. are on file.